Boehringer Ingelheim Roxane Inc is recalling Prednisone Tablet USP, 20 mg, because the blister card packaging is missing its label. The affected product consists of lot #261739A with an expiration date of OCT 2014. This issue affects 14,619 cartons distributed nationwide. Read more at govinfonow.com/recall/47450-boehringer-ingelheim-roxane-inc-recalls-prednisone-tablet-usp-20-mg.
“Recall: Boehringer Prednisone 20mg Tablets Missing Label.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/47450-boehringer-ingelheim-roxane-inc-recalls-prednisone-tablet-usp-20-mg. Based on FDA recall #D-882-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-882-2013%22&limit=1).
The FDA announced on June 14, 2013, that Boehringer Ingelheim Roxane Inc voluntarily recalled Prednisone Tablet USP, 20 mg, due to missing labels on blister cards. The recall affects 14,619 cartons distributed nationwide.
How to tell if you have it
Brand: Boehringer Ingelheim Roxane
Product: Prednisone Tablet USP 20 mg
Packaging: Blisters of ten (10) tablets per blister card, ten blister cards per carton
NDC: 0054-0018-20
Lot code: #261739A
Expiration date: OCT 2014
Quantity: 14,619 cartons
The hazard
The hazard is a missing label on the blister card. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show Boehringer Ingelheim Roxane Inc has 12 other recalls on record since 2012-11-05. Other recent recalls of similar products include FUROSEMIDE Tablets USP (2015-09-25), Combivent Respimat (2015-07-24), and Acarbose 50mg Tablets (2015-04-02). Other recent recalls of similar products include American Health Packaging Buprenorphine Tablets (2026-08-19), American Regent Levocarnitine Injection (2026-04-16), and Sandoz Focalin XR 5mg Capsules (2026-06-01).
How to tell if you have this one
Check your Prednisone Tablet USP, 20 mg packaging for lot number #261739A and an expiration date of OCT 2014. The product is packaged in blisters of ten tablets per blister card, with ten blister cards per carton.
Brand
Boehringer Ingelheim Roxane
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Your Medication
Verify if your Prednisone Tablet USP, 20 mg has lot number #261739A and an expiration date of OCT 2014.
Contact Manufacturer
Since no remedy is stated in the record, contact Boehringer Ingelheim Roxane Inc for further instructions on how to proceed with the recalled product.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 12 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-882-2013 (June 14, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-882-2013 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.